XML 18 R7.htm IDEA: XBRL DOCUMENT v3.24.0.1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($)
$ in Thousands
 6 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Cash flows from operating activities:    
Net income $ 48,158 $ 49,776
Adjustments to reconcile net income to net cash provided by (used in) operating activities:    
Gain on sale of business (14,533) 0
Depreciation and amortization 14,475 14,285
Amortization of debt issue costs 193 385
Provision for doubtful accounts 4,472 33
Share-based compensation 5,340 5,679
Deferred income taxes (1,703) 932
Finance lease interest 46 24
Changes in operating assets and liabilities:    
Accounts receivable 75,579 (49,541)
Inventories 182,168 (146,826)
Prepaid expenses and other assets (11,576) 30,487
Other non-current assets 3,208 (7,168)
Accounts payable (135,138) 33,820
Accrued expenses and other liabilities (7,678) (13,268)
Income taxes payable (6,254) 6,036
Net cash provided by (used in) operating activities 156,757 (75,346)
Cash flows from investing activities:    
Capital expenditures (4,865) (4,262)
Proceeds from sale of business, net of cash transferred 17,978 0
Net cash provided by (used in) investing activities 13,113 (4,262)
Cash flows from financing activities:    
Borrowings on revolving credit, net of expenses 1,134,629 1,232,058
Repayments on revolving credit, net of expenses (1,292,729) (1,137,897)
(Repayments) borrowings on long-term debt, net (3,165) 17,465
Repayments on finance lease obligation (442) (492)
Debt issuance costs 0 (1,407)
Exercise of stock options 4,309 634
Taxes paid on settlement of equity awards (2,657) (2,332)
Common stock repurchased (1,251) 0
Net cash (used in) provided by financing activities (161,306) 108,029
Effect of exchange rate changes on cash and cash equivalents 245 37
Increase in cash and cash equivalents 8,809 28,458
Cash and cash equivalents at beginning of period 36,178 37,987
Cash and cash equivalents at end of period $ 44,987 $ 66,445